| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bexarotene | FIMM | pan-cancer | AAC | 0.028 | 0.9 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | -0.0078 | 0.9 |
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.9 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | -0.0088 | 0.9 |
| mRNA | pac-1 | GDSC1000 | pan-cancer | AAC | 0.0061 | 0.9 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.9 |
| mRNA | ABT-263 | FIMM | pan-cancer | AAC | -0.025 | 0.9 |
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | 0.0056 | 0.9 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | -0.0053 | 0.9 |
| mRNA | Sorafenib | FIMM | pan-cancer | AAC | 0.028 | 0.9 |